United Kingdom· GB-APID-44556211000001108
Eribulin 880micrograms/2ml solution for injection vials
A eribulin product containing eribulin, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 18 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eribulin is registered in 18 of 19 countries.
Countries holding a registration under ATC L01XX41 (eribulin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Eribulin · ATC L01XX41
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eribulin
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XX41
- ATC class
- Eribulin
- Defined daily dose
- 0.21 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for eribulin.
Graded by severity as the source publishes them — 93 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eribulin · interactions on record
428 records
- 93 severe
- 331 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eribulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaERHOPANAAGmed s.r.o., Ostrava
- United Stateseribulin mesylateApotex Corp.
- SpainERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFGAdvanz Pharma Limited
- SwedenEribulin Accord 0,44 mg/ml Injektionsvätska, lösningAccord Healthcare B.V.
- FinlandEribulin AccordAccord Healthcare B.V.
- BelgiumEribulin Advanz Pharma 0.44 mg/mlAdvanz Pharma
- IcelandEribulin Advanz PharmaADVANZ PHARMA Limited
- IrelandEribulin Accord 0.44 mg/ml solution for injectionAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Eribulin Accord, Eribulin Advanz Pharma
- Belgium · Eribulin Advanz Pharma, Eribulin Eg
- Bulgaria · Eribulin Ever Pharma, Sclarint
- Czechia · Erhopana, Eribulin Accord
- Germany · Eribulin Aqvida, Eribulin Beta
- Denmark · Eribulin Accord, Eribulin Ever Pharma
- Estonia · Eribulin, Eribulin Accord
- Spain · Eribulina, Eribulina Advanz Pharma
- Finland · Eribulin, Eribulin Accord
- France · Eribuline Accord, Eribuline Advanz Pharma
- Greece · Eribulin Ever Pharma
- Croatia · Eribulin, Eribulin Accord
- Hungary · Eribulin Advz, Eribulin Ever Pharma
- Ireland · Eribulin Advanz Pharma, Eribulin Ever Pharma
- Iceland · Advz, Eribulin Advanz Pharma
- Italy · Eribulina Advanz Pharma, Eribulina Eg
- Liechtenstein · Eribulin Baxter, Halaven
- Lithuania · Eribulin, Eribulin Accord
- Luxembourg · Eribulin Eg
- Latvia · Eribulin, Eribulin Advz
- Malta · Eribulin Tillomed
- Netherlands · Eribulin Ever Pharma, Eribuline Hikma
- Norway · Eribulin Accord, Eribulin Advanz Pharma
- Poland · Eribulin Ever Pharma
- Portugal · Eribulina Advanz Pharma, Eribulina Cttq
- Romania · Erhopana, Eribulin Ever Pharma
- Sweden · Eribulin, Eribulin Accord
- Slovenia · Eribulin Ever Pharma
- Slovakia · Eribulin Advz, Eribulin Agmed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b42638ca-7fa0-4a67-82c5-a73a09d162dc GET /v1/drugs/b42638ca-7fa0-4a67-82c5-a73a09d162dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44556211000001108",
"desc": "Eribulin 880micrograms/2ml solution for injection vials (A A H Pharmaceuticals Ltd)",
"form": "Solution for injection",
"vpid": "18781111000001100",
"source": "dmd",
"vtm_id": "775817009",
"strength": "440 microgram",
"substance": "Eribulin",
"ingredient": "Eribulin mesilate",
"supplier_code": "3144701000001104"
}See everything about eribulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.